Persistently high prevalence of HPV16 and rising prevalence of non-16/18 HR-HPV genotypes in cervical precancer and cancer in Latvia in 2016-2024 shape the severity of cervical disease
HPV16 remained the most prevalent HR-HPV, while HPV18 decreased. Other HR-HPV genotypes (HPV 66/45/39/31/33) demonstrated an increase in prevalence. Cervical disease severity was linked to specific HR-HPV loads and the number infecting HR-HPVs. These findings highlight the need for extended HR-HPV genotyping with determination of viral load, and request more epidemiological studies analyzing historical and current samples.
Authors
- Arta Spridzāne
- Karina Biserova (ORCID: https://orcid.org/0000-0002-1755-3205)
- Lība Sokolovska (ORCID: https://orcid.org/0000-0002-5820-1783)
- Dmitry Perminov
- Jurijs Nazarovs
- Androniks Mitiļdžans
- Maria Isaguliants
- Daira Krišāne
- Svetlana Gebrila
- Juris Jansons
- Ilvija Krasovska
- Marta Petrovska
- Beatrise Orlova
- Alesja Dudorova
Institutions
- Latvian Biomedical Research and Study Centre (LV)
- Global University Systems (GB)
- Karolinska Institutet (SE)
- Riga East University Hospital (LV)
- Pauls Stradiņš Clinical University Hospital (LV)
- Riga Stradiņš University (LV)
- Central Research Laboratories (United Kingdom) (GB)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2026-02-04
- DOI
- https://doi.org/10.3389/fonc.2025.1676334
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00